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18 Diagnostic accuracy studies are fundamental for the assessment of diagnostic tests. Researchers 
19 need to understand the implications of their chosen design, opting for comparative designs where 
20 possible. Researchers should analyse test accuracy studies using the appropriate methods, 
21 acknowledging the uncertainty of results and avoiding overstating conclusions and ignoring the 
22 clinical situation which should inform the trade-off between sensitivity and specificity. Test accuracy 
23 studies should be reported with transparency using the STARD checklist  (1).
24
25
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27 Diagnosing diseases is crucial in medicine, and for this purpose many diagnostic tests and 
28 procedures are applied. For the diagnosis of a suspected adrenal carcinoma a CT scan is performed, 
29 and an insulin tolerance test (ITT) for adrenal insufficiency. The performance of these tests can be 
30 investigated in diagnostic accuracy studies.  
31 Medical diagnostic tests are evaluated in different ways, depending on the stage of evaluation and 
32 the purpose of the test. A fundamental aspect of the evaluation of diagnostic tests is test accuracy, 
33 that is, the ability of a test to differentiate between those who have and those who do not have the 
34 condition or disease of interest. In this article we define key terminology (see box 1) used in the 
35 context of test accuracy, and describe basic aspects of study design and analysis. 
36 Guidelines for reporting of test accuracy studies, The STAndards for the Reporting of Diagnostic 
37 accuracy studies (STARD) checklist (1), have been published and we recommend their use to 
38 increase quality and transparency of reporting. 
39
40 Measures of test accuracy
41 Test accuracy is determined by cross classifying the results (positive and negative) of an index test 
42 against those of the reference standard. This produces a two-by-two table giving the number of true 
43 positives, false positives, false negatives and true negatives, see box 2. Standard methods for 
44 estimating test accuracy require binary classification of the results of the index test and the 
45 reference standard. As such when test results are non-binary, criteria (referred to as thresholds, cut-
46 offs or cut-points) are needed to define test negatives and test positives. For example, when 
47 assessing the test accuracy for the CRH-test for adrenal insufficiency, a cut-off needs to be defined. 
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48 Measures of test accuracy should always be accompanied by a 95% confidence interval (CI), which is 
49 a measure of uncertainty for the point estimate. In example given in box 2, the 95% CI for the 
50 sensitivity ranges from 0.96 to 0.99; the 95% CI for specificity is wider, ranging from 0.67 to 0.78. 
51
52 Study population and design 
53 There are different phases in the evaluation of a diagnostic test. Firstly, test performance is 
54 determined in a population of clearly established cases and non-cases (2, 3), this referred to as 
55 proof-of-concept or exploratory study. Secondly, assessment in a representative population in an 
56 appropriate clinical setting (prospective consecutive recruitment of suspected cases) can be 
57 performed (4). The spectrum of disease will vary between these designs; researchers should be 
58 aware of this difference when planning studies and generalising results of studies to clinical settings 
59 (5, 6). When researchers perform an exploratory study  involving known cases and non-cases 
60 (referred to as a diagnostic case-control or two-gate design (2)), (positive and negative) predictive 
61 values should not be directly calculated using two-by-two data from such studies. This is because 
62 predictive values are directly related to prevalence and the proportion of participants with the target 
63 condition in case-control studies is artificial, i.e. determined by the study investigators. For example, 
64 doubling the number cases would directly affect the calculated NPV and PPV. This is not the case 
65 when a representative population is sampled, for example all pituitary adenoma patients with 
66 suspected ACTH deficiency. 
67 Test accuracy studies often evaluate a single index test but where alternative tests exist that can be 
68 used at the same point in the diagnostic pathway (providing the tests do not interfere with each 
69 other and the patient burden is not too great), these test can be evaluated in one study population 
70 (7). The ideal comparative study design is to perform all tests and the reference standard on all 
71 participants (paired or within–subject design) or to randomise participants to receive one of the 
72 index tests (8). The randomised design is preferred when it is not possible to perform multiple index 
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73 tests on each individual for ethical or logistical reasons. Additionally, the role of the test in the 




78 Sample size calculations for test accuracy studies should be determined prior to recruitment; see (9, 
79 10) for details. When evaluating a single test, a common approach is based on the precision around 
80 an estimate of sensitivity and/or specificity (i.e. width of the confidence intervals). The precision of 
81 the sensitivity estimate will increase with the number of participants with the target condition 
82 (reference standard positive) and the precision of the specificity estimate will increase with the 
83 number of participants without the target condition (reference standard negative). Hence, it is vital 
84 to have an estimate of the prevalence of the target condition to plan the sample size. 
85
86 Statistical analysis of accuracy studies
87 Measures of test accuracy (see box 1) can be calculated along with 95% confidence intervals (11, 12). 
88 For test accuracy studies comparing two tests, additionally the difference in sensitivity and 
89 specificity between the index tests can be computed. With the paired comparative design, 
90 McNemar’s test can be used to test differences in sensitivity and specificity. Alternatively, regression 
91 modelling taking into account the paired nature of the data can be performed. The effect of 
92 important clinical characteristics on test accuracy can also be explored using such models; for 
93 example it can be assessed whether age determines differences of two index tests. For the 
94 randomised comparative design, a test of independent proportions can be used to compare 
95 sensitivity and specificity between groups. 
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96 For tests with non-binary results, receiver operating characteristic (ROC) curve analysis is typically 
97 performed. There is a negative relationship between sensitivity and specificity as the cut-point 
98 changes (threshold effect); if we for example lower the cortisol threshold for the diagnosis of 
99 adrenal insufficiency, this will increase sensitivity (less false negatives), as a consequence however, 
100 the specificity will be lower (more false positives) A ROC curve displays this trade-off between 
101 sensitivity and specificity at different cut-points for a test (see figure 2), and curves for different tests 
102 in a comparative study can be compared on a single ROC plot.  A simplistic cut-point would maximise 
103 sensitivity and specificity. However, an appropriate cut-point for use in clinical practice should be 
104 driven by the consequences for false positive and false negative results. If a study is used to derive a 
105 cutpoint for a test the performance, external validation is required, as a single study will likely 
106 overestimate the test’s performance. This is especially the case for small studies. 
107
108 Concluding remarks
109 Diagnostic test accuracy studies are required to understand the potential for new diagnostic 
110 technologies. It is vital that researchers understand the implications of the design of their studies 
111 and the impact on the study conclusions. Researchers need to understand the clinical situation and 
112 weigh the consequences of misidentifying positive and negative participants. There is a need for 
113 clear and transparent reporting allowing the limitations of studies to be identified. We encourage 
114 researchers to seek specialist support when embarking on these studies.
115
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Box 1: Key terminology for test accuracy studies 
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Box 2: Example calculations, results and interpretation. TP is the number of true positive results; TN is the 
number of true positive results; FP is the number of false positive results; FN is the number of false negative 
results; PPV is the positive predictive value; NPV is the negative predictive value. 
149x97mm (120 x 120 DPI) 
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Figure 1: Robust study designs for comparing test accuracy by Y. Takwoingi (9). In (A) all patients undergo 
all index tests while in (B) patients are randomly assigned to only one of the index tests. In both (A) and 
(B), all patients receive the reference standard. Both designs are valid, although the paired design requires 
a smaller study sample. 
150x117mm (120 x 120 DPI) 
Page 12 of 13
eje@bioscientfica.com
Manuscript submitted for review to European Journal of Endocrinology
For Review Only
 
Figure 2: ROC curve example 
142x142mm (150 x 150 DPI) 
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